<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lu M</submitter><funding>Guangdong Province Medical Science and Technology Research Foundation Project</funding><pagination>373</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11998445</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Osteoarthritis (OA), a degenerative joint disease characterized by cartilage degradation and inflammation, lacks effective disease-modifying therapies. Quercetin, a bioactive flavonoid derived from Traditional Chinese Medicine, exhibits anti-inflammatory and chondroprotective properties but is limited by poor bioavailability. Mesenchymal stem cell-derived exosomes (MSC-Exos) offer a promising strategy for targeted drug delivery and cartilage regeneration.&lt;h4>Methods&lt;/h4>Bone marrow-derived MSC exosomes (Que-Exo) were isolated after preconditioning with quercetin (1µM, 24 h). Their effects were evaluated in IL-1β-stimulated chondrocytes via RT-qPCR, Western blot, transcriptomics, and proteomics. An ACLT-induced OA mouse model received intra-articular injections of Que-Exo</pubmed_abstract><journal>Journal of orthopaedic surgery and research</journal><pubmed_title>Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression.</pubmed_title><pmcid>PMC11998445</pmcid><funding_grant_id>A2024661</funding_grant_id><pubmed_authors>Lou A</pubmed_authors><pubmed_authors>Lu M</pubmed_authors><pubmed_authors>Fan W</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>He L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression.</name><description>&lt;h4>Background&lt;/h4>Osteoarthritis (OA), a degenerative joint disease characterized by cartilage degradation and inflammation, lacks effective disease-modifying therapies. Quercetin, a bioactive flavonoid derived from Traditional Chinese Medicine, exhibits anti-inflammatory and chondroprotective properties but is limited by poor bioavailability. Mesenchymal stem cell-derived exosomes (MSC-Exos) offer a promising strategy for targeted drug delivery and cartilage regeneration.&lt;h4>Methods&lt;/h4>Bone marrow-derived MSC exosomes (Que-Exo) were isolated after preconditioning with quercetin (1µM, 24 h). Their effects were evaluated in IL-1β-stimulated chondrocytes via RT-qPCR, Western blot, transcriptomics, and proteomics. An ACLT-induced OA mouse model received intra-articular injections of Que-Exo</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-10T03:08:20.734Z</modification><creation>2025-07-10T03:08:20.734Z</creation></dates><accession>S-EPMC11998445</accession><cross_references><pubmed>40229791</pubmed><doi>10.1186/s13018-025-05785-1</doi></cross_references></HashMap>